Shares

53 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$8.25 - $11.35 $3,069 - $4,222
372 Added 5.03%
7,769 $74,000
Q1 2023

May 15, 2023

SELL
$10.37 - $12.56 $9,032 - $10,939
-871 Reduced 10.53%
7,397 $77,000
Q4 2022

Jun 14, 2023

BUY
$9.9 - $12.43 $8,622 - $10,826
871 Added 11.78%
8,268 $102 Million
Q3 2022

Jun 14, 2023

BUY
$10.14 - $12.38 $8,831 - $10,782
871 Added 11.78%
8,268 $85.7 Million
Q2 2022

Jun 20, 2023

BUY
$11.05 - $12.72 $9,624 - $11,079
871 Added 11.78%
8,268 $95,000
Q2 2022

Mar 30, 2023

SELL
$11.05 - $12.72 $11,856 - $13,648
-1,073 Reduced 11.49%
8,268 $95,000
Q2 2022

Aug 11, 2022

SELL
$11.05 - $12.72 $11,856 - $13,648
-1,073 Reduced 11.49%
8,268 $95,000
Q1 2022

Jun 20, 2023

BUY
$10.61 - $12.88 $20,625 - $25,038
1,944 Added 26.28%
9,341 $117,000
Q1 2022

Mar 30, 2023

SELL
$10.61 - $12.88 $267,106 - $324,254
-25,175 Reduced 72.94%
9,341 $117,000
Q1 2022

May 12, 2022

SELL
$10.61 - $12.88 $267,106 - $324,254
-25,175 Reduced 72.94%
9,341 $118,000
Q4 2021

Jun 21, 2023

BUY
$10.86 - $13.95 $294,512 - $378,310
27,119 Added 366.62%
34,516 $402,000
Q4 2021

Mar 30, 2023

SELL
$10.86 - $13.95 $42,049 - $54,014
-3,872 Reduced 10.09%
34,516 $402,000
Q4 2021

Feb 15, 2022

SELL
$10.86 - $13.95 $42,049 - $54,014
-3,872 Reduced 10.09%
34,516 $402,000
Q3 2021

Jun 21, 2023

BUY
$11.92 - $13.92 $369,412 - $431,394
30,991 Added 418.97%
38,388 $501,000
Q3 2021

Mar 30, 2023

SELL
$11.92 - $13.92 $79,017 - $92,275
-6,629 Reduced 14.73%
38,388 $501,000
Q3 2021

Nov 15, 2021

SELL
$11.92 - $13.92 $79,017 - $92,275
-6,629 Reduced 14.73%
38,388 $501,000
Q2 2021

Jun 21, 2023

BUY
$10.16 - $13.11 $382,219 - $493,198
37,620 Added 508.58%
45,017 $579,000
Q2 2021

Mar 30, 2023

BUY
$10.16 - $13.11 $21,488 - $27,727
2,115 Added 4.93%
45,017 $579,000
Q2 2021

Aug 16, 2021

BUY
$10.16 - $13.11 $456,935 - $589,609
44,974 Added 104590.7%
45,017 $579,000
Q1 2021

Jun 26, 2023

BUY
$9.04 - $11.86 $320,965 - $421,089
35,505 Added 479.99%
42,902 $480 Million
Q1 2021

Mar 30, 2023

BUY
$9.04 - $11.86 $13,876 - $18,205
1,535 Added 3.71%
42,902 $479,000
Q1 2021

May 14, 2021

SELL
$9.04 - $11.86 $373,568 - $490,102
-41,324 Reduced 99.9%
43 $480,000
Q4 2020

Jun 22, 2023

BUY
$9.05 - $12.2 $307,428 - $414,434
33,970 Added 459.24%
41,367 $471,000
Q4 2020

Mar 30, 2023

SELL
$9.05 - $12.2 $21,756 - $29,328
-2,404 Reduced 5.49%
41,367 $471,000
Q4 2020

Feb 16, 2021

SELL
$9.05 - $12.2 $21,756 - $29,328
-2,404 Reduced 5.49%
41,367 $471,000
Q3 2020

Jun 26, 2023

BUY
$8.99 - $10.74 $327,002 - $390,656
36,374 Added 491.74%
43,771 $393,000
Q3 2020

Mar 30, 2023

SELL
$8.99 - $10.74 $48,348 - $57,759
-5,378 Reduced 10.94%
43,771 $393,000
Q3 2020

Nov 13, 2020

SELL
$8.99 - $10.74 $48,348 - $57,759
-5,378 Reduced 10.94%
43,771 $394,000
Q2 2020

Jun 26, 2023

BUY
$9.14 - $11.97 $381,613 - $499,771
41,752 Added 564.45%
49,149 $507,000
Q2 2020

Mar 30, 2023

SELL
$9.14 - $11.97 $3,829 - $5,015
-419 Reduced 0.85%
49,149 $507,000
Q2 2020

Aug 14, 2020

SELL
$9.14 - $11.97 $3,829 - $5,015
-419 Reduced 0.85%
49,149 $507,000
Q1 2020

Jul 12, 2023

BUY
$8.58 - $14.01 $366,280 - $598,086
42,690 Added 577.13%
50,087 $505,000
Q1 2020

Mar 30, 2023

BUY
$8.58 - $14.01 $2,273 - $3,712
265 Added 0.54%
49,568 $500,000
Q1 2020

May 15, 2020

BUY
$8.58 - $14.01 $2,273 - $3,712
265 Added 0.54%
49,568 $500,000
Q4 2019

Jul 12, 2023

BUY
$8.22 - $14.0 $344,467 - $586,684
41,906 Added 566.53%
49,303 $656,000
Q4 2019

Mar 30, 2023

SELL
$8.22 - $14.0 $12,823 - $21,840
-1,560 Reduced 3.07%
49,303 $656,000
Q4 2019

Feb 14, 2020

SELL
$8.22 - $14.0 $12,823 - $21,840
-1,560 Reduced 3.07%
49,303 $656,000
Q3 2019

Jul 12, 2023

BUY
$8.59 - $10.96 $373,372 - $476,387
43,466 Added 587.62%
50,863 $436,000
Q3 2019

Mar 30, 2023

BUY
$8.59 - $10.96 $52,330 - $66,768
6,092 Added 13.61%
50,863 $436,000
Q3 2019

Nov 14, 2019

BUY
$8.59 - $10.96 $52,330 - $66,768
6,092 Added 13.61%
50,863 $437,000
Q2 2019

Jul 12, 2023

BUY
$9.8 - $12.89 $366,265 - $481,750
37,374 Added 505.26%
44,771 $489,000
Q1 2019

Jul 13, 2023

BUY
$8.27 - $12.73 $309,082 - $475,771
37,374 Added 505.26%
44,771 $507,000
Q1 2019

Mar 30, 2023

BUY
$8.27 - $12.73 $301,879 - $464,683
36,503 Added 441.5%
44,771 $507,000
Q1 2019

May 16, 2019

BUY
$8.27 - $12.73 $341,865 - $526,232
41,338 Added 1204.14%
44,771 $605,000
Q1 2019

May 15, 2019

SELL
$8.27 - $12.73 $341,865 - $526,232
-41,338 Reduced 92.33%
3,433 $79,000
Q4 2018

Jul 13, 2023

BUY
$7.8 - $16.13 $291,517 - $602,842
37,374 Added 505.26%
44,771 $388,000
Q4 2018

Feb 14, 2019

BUY
$7.8 - $16.13 $268,101 - $554,420
34,372 Added 330.53%
44,771 $464,000
Q3 2018

Jul 13, 2023

BUY
$14.31 - $17.65 $534,821 - $659,651
37,374 Added 505.26%
44,771 $826 Million
Q3 2018

Nov 14, 2018

SELL
$14.31 - $17.65 $491,863 - $606,665
-34,372 Reduced 76.77%
10,399 $192,000
Q2 2018

Aug 15, 2018

BUY
$11.83 - $16.2 $11,001 - $15,066
930 Added 2.12%
44,771 $0
Q1 2018

May 15, 2018

BUY
$11.13 - $13.63 $19,099 - $23,389
1,716 Added 4.07%
43,841 $0
Q4 2017

Feb 15, 2018

SELL
$12.16 - $14.58 $597,749 - $716,709
-49,157 Reduced 53.85%
42,125 $631,000
Q2 2017

Aug 14, 2017

BUY
N/A
91,282
91,282 $1.72 Million

Others Institutions Holding IRWD

About IRONWOOD PHARMACEUTICALS INC


  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $541M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.